Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aztreonam. Diffusion into bronchial mucus].

C Morel, M Vergnaud, B Malbruny

    Pathologie-Biologie
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cross-species dissection of the modular role of the ventral tegmental area in depressive disorders.

    Neuroscience·2025
    Same author

    Comparison of predictive validity of two autism spectrum disorder rat models: Behavioural investigations.

    Neurotoxicology·2024
    Same author

    Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to α-Hexabromocyclododecane.

    Environmental toxicology and pharmacology·2023
    Same author

    Effect of obesity on gastrointestinal transit, pressure and pH using a wireless motility capsule.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
    Same author

    [Intraoperative photo of fluocinolone acetonide and dexamethasone implants].

    Journal francais d'ophtalmologie·2021
    Same author

    New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product.

    Acta biomaterialia·2020
    Same journal

    Pathologie-biologie·2020
    Same journal

    Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

    Pathologie-biologie·2015
    Same journal

    [Not Available].

    Pathologie-biologie·2015
    Same journal

    Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

    Pathologie-biologie·2015
    Same journal

    Biological diagnosis of diabetes mellitus.

    Pathologie-biologie·2015
    Same journal

    Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

    Pathologie-biologie·2015
    See all related articles

    Aztreonam, a new antibiotic, showed low concentrations in bronchial mucus for chronic bronchitis patients. Mucus levels were significantly lower than serum levels, suggesting limited diffusion.

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Infectious Diseases

    Background:

    • Antibiotic penetration into respiratory secretions is crucial for treating bacterial lung infections.
    • Beta-lactam antibiotics, including monobactams like aztreonam, are commonly used but their efficacy can be limited by poor mucus diffusion.
    • Understanding aztreonam's diffusion into bronchial mucus is essential for optimizing treatment of chronic bronchitis exacerbations.

    Purpose of the Study:

    • To investigate the diffusion of aztreonam into human bronchial mucus.
    • To compare serum and mucus concentrations of aztreonam in patients with acute purulent exacerbation of chronic bronchitis.
    • To evaluate the impact of treatment duration on aztreonam concentrations in mucus.

    Main Methods:

    • Prospective study involving 20 patients with chronic bronchitis.

    Related Experiment Videos

  • Aztreonam (1 g twice daily) administered for acute purulent exacerbation.
  • Serum and bronchial mucus samples collected at 0.5, 1, 1.5, and 3 hours post-dose on days 1 and 3.
  • Antibiotic concentrations determined using agar diffusion and High-Performance Liquid Chromatography (HPLC).

    • Main Results:

    • Aztreonam concentrations in bronchial mucus were consistently low, ranging from 0.27 to 1.15 mg/l.
    • Mucus levels were significantly lower than concurrent serum concentrations (e.g., 30-90 mg/l).
    • Concentrations showed some variation based on time post-dose and treatment day, but remained low.

    Conclusions:

    • Aztreonam exhibits limited diffusion into human bronchial mucus.
    • The observed low mucus concentrations may impact its efficacy in treating bacterial respiratory tract infections.
    • Further studies are needed to assess the clinical significance of these findings for aztreonam therapy in chronic bronchitis.